Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

SXTC

China SXT Pharmaceuticals (SXTC)

China SXT Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SXTC
DateTimeSourceHeadlineSymbolCompany
11/05/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SXTCChina SXT Pharmaceuticals Inc
10/25/202412:19PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:SXTCChina SXT Pharmaceuticals Inc
10/22/20244:51PMEdgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:SXTCChina SXT Pharmaceuticals Inc
10/15/20244:15PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SXTCChina SXT Pharmaceuticals Inc
10/07/20244:15PMGlobeNewswire Inc.China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price DeficiencyNASDAQ:SXTCChina SXT Pharmaceuticals Inc
08/13/20244:15PMEdgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:SXTCChina SXT Pharmaceuticals Inc
07/31/20244:15PMEdgar (US Regulatory)Form NT 20-F - Notification of inability to timely file Form 20-FNASDAQ:SXTCChina SXT Pharmaceuticals Inc
05/14/20244:15PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SXTCChina SXT Pharmaceuticals Inc
01/11/20244:31PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SXTCChina SXT Pharmaceuticals Inc
10/26/20234:05PMGlobeNewswire Inc.China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price RuleNASDAQ:SXTCChina SXT Pharmaceuticals Inc
10/04/20238:30AMGlobeNewswire Inc.China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock SplitNASDAQ:SXTCChina SXT Pharmaceuticals Inc
07/31/20234:15PMEdgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:SXTCChina SXT Pharmaceuticals Inc
05/19/20235:17PMEdgar (US Regulatory)Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
05/10/20238:00AMGlobeNewswire Inc.China SXT Pharmaceuticals, Inc. Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price RuleNASDAQ:SXTCChina SXT Pharmaceuticals Inc
03/29/20232:20PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
03/29/20231:50PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
03/27/20236:02AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(7) (424b7)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
02/28/20234:06PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
02/24/20235:20PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
02/13/20234:29PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
12/23/20226:05AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
11/07/20228:00AMGlobeNewswire Inc.China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price DeficiencyNASDAQ:SXTCChina SXT Pharmaceuticals Inc
10/12/20228:46AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
09/27/20228:01AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
07/18/202211:02AMEdgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
05/18/202212:30PMGlobeNewswire Inc.China SXT Pharmaceuticals, Inc. Announces 1 for 20 Reverse Share SplitNASDAQ:SXTCChina SXT Pharmaceuticals Inc
05/13/20224:09PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
05/11/20224:06PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
03/24/20224:32PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
03/16/20224:06PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:SXTC

Your Recent History

Delayed Upgrade Clock